Arcus Biosciences Inc (RCUS)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -283,000 | -307,000 | -267,000 | 53,000 | -123,000 |
| Total assets | US$ in thousands | 1,150,000 | 1,095,000 | 1,345,000 | 1,592,000 | 772,292 |
| ROA | -24.61% | -28.04% | -19.85% | 3.33% | -15.93% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $-283,000K ÷ $1,150,000K
= -24.61%
Based on the provided data for Arcus Biosciences Inc's Return on Assets (ROA), the company's performance in utilizing its assets to generate profits has fluctuated over the years. In December 31, 2020, the ROA was negative at -15.93%, indicating that the company incurred losses relative to its assets. Subsequently, in December 31, 2021, the ROA improved to 3.33%, signaling a positive return on assets.
However, the company faced challenges in the following years, with ROA figures declining significantly. By December 31, 2022, the ROA dropped to -19.85%, and in the subsequent years, the trend worsened with ROA values of -28.04% in 2023 and -24.61% in 2024. These negative ROA percentages suggest that Arcus Biosciences Inc experienced difficulties in generating profits relative to the size of its asset base during those years.
Overall, the fluctuating ROA figures highlight the importance of monitoring the company's efficiency in utilizing its assets to drive profitability and the need for strategic management decisions to improve financial performance.
Peer comparison
Dec 31, 2024